H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) shares passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares changing hands.
H. Lundbeck A/S Stock Performance
The firm has a market cap of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The stock’s 50 day moving average is $22.00 and its 200 day moving average is $22.00. The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Stories
- Five stocks we like better than H. Lundbeck A/S
- Using the MarketBeat Dividend Tax Calculator
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- What is the MACD Indicator and How to Use it in Your Trading
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- How to trade penny stocks: A step-by-step guide
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.